Interesting ImagesHepatosplenic Tuberculosis on Pretherapy and Posttherapy FDG PET/CTJin, Xiaona MD; Huo, Li MD, PhD; Wang, Tong MD; Liu, Yu BS; Li, Fang MDAuthor Information From the Department of Nuclear Medicine; and Beijing Key Laboratory of Molecular Targeted Diagnosis and Therapy in Nuclear Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China. Received for publication September 16, 2019; revision accepted September 18, 2019. Conflicts of interest and sources of funding: none declared. This work was sponsored in part by the National Natural Science Foundation of China (grant 81801741, 81601551). Correspondence to: Fang Li, MD, Department of Nuclear Medicine, Peking Union Medical College Hospital, 1# Shuaifuyuan, Dongcheng District, Beijing, China, 100730. E-mail: email@example.com. Online date: December 24, 2019 Clinical Nuclear Medicine: February 2020 - Volume 45 - Issue 2 - p 174-176 doi: 10.1097/RLU.0000000000002858 Buy Metrics Abstract A 65-year-old woman underwent FDG PET/CT for presumed hepatosplenic malignancy suggested by an abdominal CT. The images revealed multiple foci of intense FDG activity in both the liver and the spleen. However, a splenic biopsy result revealed no malignant cells, and either tuberculosis or sarcoidosis was proposed. Following an incomplete antituberculosis therapy, a repeat FDG PET/CT showed resolution of the abnormal activity in the liver and the spleen. Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.